Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 26Active not recruiting 7Recruiting 3Withdrawn 2Unknown 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Disease 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Paclitaxel 28Trastuzumab 22Cyclophosphamide 21Doxorubicin 14Docetaxel 14Carboplatin 11exemestane 10Radiotherapy 10Letrozole 10Capecitabine 10pembrolizumab 8Lapatinib 8Fulvestrant 8Neoadjuvant Therapy 6Goserelin 6Bevacizumab 6Anastrozole 6pertuzumab 5palbociclib 5eribulin 5abemaciclib 5Therapeutics 5Magnetic Resonance Spectroscopy 5Epirubicin 5Chemotherapy, Adjuvant 5Aromatase Inhibitors 5tucatinib 4Vinorelbine 4Taxes 4Tamoxifen 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Withdrawn × Breast Neoplasms × Counseling × Clear all
NCT00530751 2015-10-02

Views on Sharing Family Medical History in Healthy Women Undergoing Mammograms or Breast Evaluation

Case Comprehensive Cancer Center

Withdrawn
Breast

Breast Neoplasms

NCT00712621 2009-11-24

Determining Quality of Life in Breast Cancer Patient After Completing Radiation,Chemotherapy,Surgery or Combination

American Scitech International

Phase 2 Withdrawn
460 enrolled
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡